Literature DB >> 31868281

Biomimetic Synthesis of Rhytidenone A and Mode of Action of Cytotoxic Rhytidenone F.

Zongwei Yue1,2, Hiu C Lam2, Kaiqi Chen2, Ittipon Siridechakorn2, Yaxi Liu2, Khanitha Pudhom3, Xiaoguang Lei2.   

Abstract

The rhytidenone family comprises spirobisnaphthalene natural products isolated from the mangrove endophytic fungus Rhytidhysteron rufulum AS21B. The biomimetic synthesis of rhytidenone A was achieved by a Michael reaction/aldol/lactonization cascade in a single step from the proposed biosynthetic precursor rhytidenone F. Moreover, the mode of action of the highly cytotoxic rhytidenone F was investigated. The pulldown assay coupled with mass spectrometry analysis revealed the target protein PA28γ is covalently attached to rhytidenone F at the Cys92 residue. The interactions of rhytidenone F with PA28γ lead to the accumulation of p53, which is an essential tumor suppressor in humans. Consequently, the Fas-dependent signaling pathway is activated to initiate cellular apoptosis. These studies have identified the first small-molecule inhibitor targeting PA28γ, suggesting rhytidenone F may serve as a promising natural product lead for future anticancer drug development.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  apoptosis; cytotoxicity; drug discovery; natural products; proteins

Year:  2020        PMID: 31868281     DOI: 10.1002/anie.201914257

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Total synthesis, structure revision and cytotoxic activity of Sch 53825 and its derivatives.

Authors:  Leichuan Xu; Haoyun Ma; Xinkun An; Yihao Li; Qian Zhang; Xinlei Liu; Mingan Wang
Journal:  RSC Adv       Date:  2022-06-14       Impact factor: 4.036

2.  Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines.

Authors:  Long Cheng; Yan Wang; Jiawei Wang; Haibo Qin; Guangbiao Zhu; Lingsong Tao
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.